HomePharma

Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Life Sciences Times - September 1, 2026

Pharma

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Life Sciences Times - September 1, 2026

Pharma

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Life Sciences Times - August 31, 2026

Pharma

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Life Sciences Times - August 31, 2026

Pharma

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Life Sciences Times - August 31, 2026

Pharma

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Life Sciences Times - February 23, 2021 0

Pharma

Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients

Life Sciences Times - February 22, 2021 0

Pharma

Xlife Sciences AG: Antiviral drug candidate for SARS-CoV-2

Life Sciences Times - February 17, 2021 0

Pharma

M6P Therapeutics Presents Promising Preclinical Data in Lysosomal Storage Disorders at the 17th Annual WORLDSymposium™ 2021

Life Sciences Times - February 11, 2021 0

Pharma

Drug Topics® Announces Partnership with inPharmacyJobs

Life Sciences Times - February 11, 2021 0

Pharma

New Zealand approves 1st Covid-19 vaccine

Life Sciences Times - February 10, 2021 0

Pharma

Global Anti-inflammatory Drugs Market to Surpass US$ 142,223.4 Million by 2027, Says Coherent Market Insights

Life Sciences Times - February 8, 2021 0

Pharma

COVAXX’s COVID-19 Vaccine, UB-612, Induced Neutralizing Antibodies in 100% of Participants During Phase 1 Clinical Trial

Life Sciences Times - February 8, 2021 0

Pharma

AstraZeneca’s anti-diabetic drug gets nod for kidney disease in India

Life Sciences Times - February 8, 2021 0

Pharma

Reverie Labs Raises $25 Million Series A Round

Life Sciences Times - February 5, 2021 0

Pharma

MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

Life Sciences Times - February 4, 2021 0

Pharma

AstraZeneca says vaccine 76% effective for 90 days after single dose

Life Sciences Times - February 3, 2021 0

1...949596...99 Page 95 of 99

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

September 1, 2026

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

September 1, 2026

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

September 1, 2026

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

September 1, 2026

Pharma

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

Ascletis Doses First Participant in Global Phase 3 Program for Oral GLP-1 Drug ASC30

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Most Read

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

EDITOR PICKS

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

THIS WEEK'S STORIES

Wisner Baum Attorneys Named to Leadership Roles in Boston Scientific Spinal Cord Stimulator Litigation

Amgen Reports Repatha Reduced Risk of Death in High-Risk Patients Without Prior Heart Attack or Stroke

TEZSPIRE Meets All Primary and Key Secondary Endpoints in Phase III Eosinophilic Esophagitis Trial

POPULAR CATEGORY

ABOUT US

FOLLOW US